THEMISMED132.00

Themis Medicare Limited

· Pharma & Health
AnnualQuarterly₹ CrorePeersLINCOLNBAJAJHCARESIGACHIWANBURYAMRUTANJANAHCLANUHPHRMcap ₹1,216 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations381.8405.5342.2331.6
Other Income4.84.79.49.2
Total Income386.5410.2351.6340.8
Expenses
+ Cost of Materials Consumed84.776.357.362.5
+ Purchases of Stock-in-Trade53.673.763.091.1
+ Changes in Inventories-1.6-18.09.2-18.6
+ Employee Benefit Expense82.496.493.590.9
+ Finance Costs9.410.010.711.2
+ Depreciation & Amortisation12.29.910.310.3
+ Other Expenses111.1128.1118.9147.7
Total Expenses351.9376.4362.9395.1
EBITDA51.549.00.4-41.9
EBIT39.339.1-9.9-52.3
Profit
PBT before Exceptional Items34.633.7-11.3-54.3
+ Exceptional Items0.00.0-0.992.1
Pretax Income34.633.7-12.137.8
+ Current Tax9.28.30.08.3
+ Deferred Tax0.71.50.86.4
Tax Expense9.99.80.814.6
+ Share of Associates & JVs18.85.914.016.8
Net Income43.529.81.140.0
+ Net Income — Continuing Ops24.723.9-12.923.2
+ Other Comprehensive Income-0.7-0.3-0.7-0.8
Total Comprehensive Income42.829.50.539.1
Net Income to Common43.529.81.140.0
Minority Interest-0.0-0.0-0.0-0.0
Per Share
Basic EPS4.733.240.124.34
Diluted EPS4.723.240.124.33
Other Comprehensive Income — detail
+ Other Comprehensive Income-0.3-0.7-0.8
+ Items NOT to be Reclassified to P&L-1.0-0.4-1.0-1.1
+ Tax on Items NOT to be Reclassified-0.1-0.3-0.3
+ Tax on Items NOT to be Reclassified — alt tag-0.2
+ Items to be Reclassified to P&L0.00.0
Comprehensive Income — Owners of Parent42.829.5-0.730.2
Comprehensive Income — Non-controlling Interests-0.0-0.00.00.0
Per Share — as-filed variants
Basic EPS — Continuing Operations4.733.240.124.34
Diluted EPS — Continuing Operations4.723.240.124.33
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit245.0273.5212.8196.6
Gross Margin %64.1967.4562.1759.27
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)34.633.7-11.3-54.3
− Exceptional Items (reconciliation)0.00.0-0.992.1
Net Income Adj (tax-effected)43.529.82.0-16.5
EPS Adj4.733.240.21-1.79
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value1.001.001.001.00
Paid Up Equity Capital9.29.29.29.2
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.